PACSIN2 and acute lymphoblastic leukemia: In conclusion, although PACSIN2 has previously been identified as influencing gastrointestinal toxicity during consolidation therapy, this is, to our knowledge, the first study showing its association with hematological toxicity in ALL patients undergoing maintenance therapy, a finding consistently detected by different statistical methods.